Monaco Asset Management SAM - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 4 filers reported holding FATE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Monaco Asset Management SAM ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,917,641
-18.1%
1,847,944
+83.8%
1.16%
-13.0%
Q2 2023$4,784,876
-13.5%
1,005,226
+3.6%
1.34%
-21.2%
Q1 2023$5,530,670
+119.3%
970,293
+288.1%
1.70%
+122.7%
Q4 2022$2,522,500250,0000.76%
Other shareholders
FATE THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$34,0959.92%
Redmile Group, LLC 12,957,222$130,738,3705.35%
GCM Grosvenor Holdings, LLC 1,037,256$10,465,9132.67%
Casdin Capital, LLC 2,050,000$20,684,5001.60%
DAFNA Capital Management LLC 550,940$5,558,9851.57%
Artal Group S.A. 2,600,000$26,2341.46%
Monaco Asset Management SAM 250,000$2,522,5000.76%
Parametrica Management Ltd 32,254$325,4430.67%
Boxer Capital, LLC 1,250,000$12,612,5000.66%
Bellevue Group AG 4,861,279$49,050,3050.65%
View complete list of FATE THERAPEUTICS INC shareholders